News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
New Highly Sensitive Hepatitis Test Detects Mutant Virus Strains
11-Nov-2011 - Abbott announced it has received CE Marking (Conformité Européenne) in the European Union to market a new, highly sensitive diagnostic test for detection of hepatitis B surface antigen (HBsAg). The test is performed on Abbott's ARCHITECT® system. HBsAg assays may be used to help identify acute ...
12-Oct-2011 - Biotron Limited has headline results from its Phase 2a trial of its lead drug candidate, BIT225 in Hepatitis C virus (HCV) infected patients. Preliminary analysis of trial data confirms that BIT225, an orally administered, small molecule drug, has good antiviral activity against HCV. Patients ...
29-Sep-2011 - Agenix said it had filed an international method of manufacture patent application under the Patent Cooperation Treaty (PCT) for its hepatitis B drug AGX-1009. The application covers the manufacturing process of a compound that uses the same active ingredient, Tenofovir, used in the US Food & ...
06-Sep-2011 - ARTES Biotechnology and NL Biotechnologies started a strategic collaboration. With signing this collaboration agreement the two companies combine their know-how and technologies in yeast expression, process and vaccine development. The direct and noticeable aim is the marketing of efficient and ...
06-Jul-2011 - A genome-wide study by researchers at the RIKEN Center for Genomic Medicine, Hiroshima University Hospital and Sapporo-Kosei General Hospital has identified a genetic variant associated with the development of liver cancer in chronic hepatitis C virus carriers. The findings are based on a study ...
24-Jun-2011 - Medivir AB announced the start of a phase Ib clinical trial with TMC649128 intended for the treatment of chronic hepatitis C virus (HCV) infection.TMC649128 is a nucleoside NS5B polymerase inhibitor developed in collaboration with Tibotec Pharmaceuticals. TMC649128 has demonstrated an ...
25-May-2011 - An international team of researchers led by the University of Florida has created a new way to analyze the spread of dangerous viruses, according to a study published in Nature Communications. The method uses sets of mathematical rules to do something software cannot easily accomplish — analyze ...
24-May-2011 - Medivir AB announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either ...
08-Apr-2011 - Roche Diagnosticsis cooperating with the Spanish Vall d’Hebron Institute of Research (VHIR), the Networking Biomedical Research Centre in Liver and Digestive Diseases (CIBEREHD), and the software producer Advanced Biological Laboratories Therapy Edge Spain (ABL) in a study designed to resolve the ...
06-Apr-2011 - Abbott and Enanta Pharmaceuticals announced 12-week results from a Phase 2 study of ABT-450/r, an investigational, oral protease inhibitor being developed for the treatment of hepatitis C (HCV) infection. Study results show that 92 percent (22 of 24) of patients taking ABT-450/r once daily, ...
© 1997-2024 LUMITOS AG, All rights reserved